Hayden-Ledbetter M - Search Results

1

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

Scholler N, Hayden-Ledbetter M, Hellström KE, Hellström I, Ledbetter JA. Scholler N, et al. J Immunol. 2001 Mar 15;166(6):3865-72. doi: 10.4049/jimmunol.166.6.3865. J Immunol. 2001. PMID: 11238630

2

Cutting edge: CD83 regulates the development of cellular immunity.

Scholler N, Hayden-Ledbetter M, Dahlin A, Hellström I, Hellström KE, Ledbetter JA. Scholler N, et al. Among authors: hayden ledbetter m. J Immunol. 2002 Mar 15;168(6):2599-602. doi: 10.4049/jimmunol.168.6.2599. J Immunol. 2002. PMID: 11884422

3

Characterization of human inducible costimulator ligand expression and function.

Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA. Aicher A, et al. J Immunol. 2000 May 1;164(9):4689-96. doi: 10.4049/jimmunol.164.9.4689. J Immunol. 2000. PMID: 10779774

4

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

Ye Z, Hellström I, Hayden-Ledbetter M, Dahlin A, Ledbetter JA, Hellström KE. Ye Z, et al. Among authors: hayden ledbetter m. Nat Med. 2002 Apr;8(4):343-8. doi: 10.1038/nm0402-343. Nat Med. 2002. PMID: 11927939

5

Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex.

Law CL, Hayden-Ledbetter M, Buckwalter S, McNeill L, Nguyen H, Habecker P, Thorne BA, Dua R, Ledbetter JA. Law CL, et al. Among authors: hayden ledbetter m. Int Immunol. 2002 Apr;14(4):389-400. doi: 10.1093/intimm/14.4.389. Int Immunol. 2002. PMID: 11934875

6

CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer.

Hellstrom I, Ledbetter JA, Scholler N, Yang Y, Ye Z, Goodman G, Pullman J, Hayden-Ledbetter M, Hellstrom KE. Hellstrom I, et al. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6783-8. doi: 10.1073/pnas.021557498. Epub 2001 May 22. Proc Natl Acad Sci U S A. 2001. PMID: 11371607 Free PMC article.

7

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE. Hellström I, et al. Among authors: hayden ledbetter m. Cancer Res. 2003 Jul 1;63(13):3695-700. Cancer Res. 2003. PMID: 12839961

8

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Scholler N, Garvik B, Hayden-Ledbetter M, Kline T, Urban N. Scholler N, et al. Among authors: hayden ledbetter m. Cancer Lett. 2007 Mar 8;247(1):130-6. doi: 10.1016/j.canlet.2006.03.029. Epub 2006 May 4. Cancer Lett. 2007. PMID: 16677756 Free PMC article.

9

Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.

Richter G, Hayden-Ledbetter M, Irgang M, Ledbetter JA, Westermann J, Körner I, Daemen K, Clark EA, Aicher A, Pezzutto A. Richter G, et al. Among authors: hayden ledbetter m. J Biol Chem. 2001 Dec 7;276(49):45686-93. doi: 10.1074/jbc.M108509200. Epub 2001 Sep 24. J Biol Chem. 2001. PMID: 11571308 Free article.

10

CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells.

Hayden-Ledbetter MS, Cerveny CG, Espling E, Brady WA, Grosmaire LS, Tan P, Bader R, Slater S, Nilsson CA, Barone DS, Simon A, Bradley C, Thompson PA, Wahl AF, Ledbetter JA. Hayden-Ledbetter MS, et al. Clin Cancer Res. 2009 Apr 15;15(8):2739-46. doi: 10.1158/1078-0432.CCR-08-1694. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page